CD8+ T Cells Mediate RAS-Induced Psoriasis-Like Skin Inflammation through IFN-γ  by Gunderson, Andrew J. et al.
CD8þ T Cells Mediate RAS-Induced Psoriasis-Like
Skin Inflammation through IFN-c
Andrew J. Gunderson1, Javed Mohammed1, Frank J. Horvath1, Michael A. Podolsky1, Cherie R. Anderson1 and
Adam B. Glick1
The RAS signaling pathway is constitutively activated in psoriatic keratinocytes. We expressed activated H-RASV12G
in suprabasal keratinocytes of adult mice and observed rapid development of a psoriasis-like skin phenotype
characterized by basal keratinocyte hyperproliferation, acanthosis, hyperkeratosis, intraepidermal neutrophil
microabscesses, and increased T helper type 1 (Th1)/Th17 and T cell type 1 (Tc1)/Tc17 skin infiltration. The majority
of skin-infiltrating CD8þ T cells coexpressed IFN-g and IL-17A. When RAS was expressed on a Rag1 /
background, microabscess formation, inducible nitric oxide synthase expression, and keratinocyte hyperproli-
feration were suppressed. Depletion of CD8þ , but not CD4þ , T cells reduced cutaneous and systemic
inflammation, the RAS-induced increase in cutaneous Th17 and IL-17þ gd T cells, and epidermal hyperprolifera-
tion to levels similar to a Rag1 / background. Reconstitution of Rag1 / inducible RAS mice with purified
CD8þ T cells restored microabscess formation and epidermal hyperproliferation. Neutralization of IFN-g, but not
of IL-17A, in CD8þ T-cell-reconstituted Rag1 / mice expressing RAS blocked CD8-mediated skin inflammation,
inducible nitric oxide synthase expression, and keratinocyte hyperproliferation. These results show that CD8þ
T cells can orchestrate skin inflammation with psoriasis-like pathology in response to constitutive RAS activation
in keratinocytes, and this is primarily mediated through IFN-g.
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INTRODUCTION
Psoriasis is a chronic inflammatory disease of the skin char-
acterized by keratinocyte hyperproliferation with parakeratosis,
increased angiogenesis, and dermal and epidermal infiltration of
inflammatory cells, including CD4þ and CD8þ T cells, neutro-
phils, macrophages, and dendritic cells (Monteleone et al.,
2011). RAS is a small GTPase regulated by growth factor
receptors such as EGFR and signals through multiple pathways
to activate gene expression and cell proliferation (Wennerberg
et al., 2005). Abnormalities in the RAS–RAF–MAPK (mitogen-
activated protein kinase) pathway in keratinocytes have been
linked to the pathophysiology of psoriasis. RAS activity, but not
expression, is elevated in psoriatic lesions independent of an
inflammatory microenvironment (Lin et al., 1999), possibly
owing to reduced levels of the neurofibromatosis type 1
protein (Karvonen et al., 2004). RAS effectors, including the
MAPKs, p38, ERK1/2 (extracellular signal–regulated kinase-1/2),
and MSK1 (mitogen- and stress-activated protein kinase-1), are
also elevated in psoriatic lesions, associated with the activation
of transcription factors regulating proinflammatory cytokine
gene expression (Funding et al., 2006; Yu et al., 2007).
Transgenic mice overexpressing components of the RAS–RAF–
MAPK pathway in basal or suprabasal keratinocytes phenocopy
certain aspects of the hyperproliferative and inflammatory
phenotype of psoriasis (Hobbs et al., 2004; Tarutani et al.,
2010), including neutrophil and T-cell infiltration. Similarly,
basal or suprabasal expression of amphiregulin, an EGFR ligand
likely to activate the RAS pathway, generates a psoriasiform skin
phenotype (Cook et al., 1997, 2004).
Many studies have documented the importance of both
T helper type 1 (Th1)- and Th17-polarized CD4þ T cells and
more recently CD8þ T cells in the pathogenesis of psoriasis
(Monteleone et al., 2011). There are increased numbers of
circulating and skin-infiltrating IFN-g-producing T cells and
increased activation of many IFN-g-induced immune response
genes in psoriatic plaques (Austin et al., 1999), as well as
increased numbers of Th17 cells that enhance and maintain
the proinflammatory phenotype in T cells and keratinocytes
and can contribute to keratinocyte hyperproliferation (Kolls
and Linden, 2004; Zheng et al., 2007; Caruso et al., 2009;
Di Cesare et al., 2009; Monteleone et al., 2011). Psoriatic
lesions also contain increased numbers of both IFN-g- and
IL-17-producing CD8þ T cells (Kryczek et al., 2008; Ortega
et al., 2009; Res et al., 2010). Recent studies suggest that
there is more plasticity between T cell type 1 (Tc1) and Tc17
polarized states than for CD4þ T cells, as Tc17 cells from
psoriatic lesions coexpressed both IFN-g and IL-17, as well as
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other Th1- and Th17-lineage cytokines and possessed cyto-
toxic activity (Ortega et al., 2009). However, in vitro Tc17
polarization is linked to a loss of cytotoxic functionality
(Huber et al., 2009; Yen et al., 2009). The importance of
these CD8þ T cells in the disease process has not been
determined.
Although mouse models of RAS pathway activation recapi-
tulate many of the key histopathological features of psoriasis,
less is known about the effects on polarization of skin-
infiltrating CD4þ and CD8þ T cells. To assess this, we have
expressed an activated human Ha-RASV12G gene in the
suprabasal layer of the epidermis of adult mice using an
Involucrin (Inv) promoter–driven tetracycline transactivator
(tTA) (Jaubert et al., 2004). Our results show that suprabasal
expression of RAS causes a CD8þ T-cell-dependent psoriasis-
like skin phenotype requiring IFN-g.
RESULTS
Suprabasal RAS expression causes basal keratinocyte
hyperproliferation and cutaneous inflammation associated with
intraepidermal neutrophil microabscesses
Seven days after doxycycline (dox) removal, InvtTA
tetORASV12G double-transgenic (DT) mice had overt pheno-
typic changes, including scruffy hair coat, scaling, and
inflamed ears and tails, with no change in single-transgenic
(ST) littermates (Figure 1a), in parallel with transgene induction
(Supplementary Figure S1a). The skin of DT mice was
hyperkeratotic, acanthotic, and parakeratotic (Figure 1c), cor-
relating with increased proliferation in the basal layer
(Figure 1d). Extensive enlargement of dermal vasculature
was also evident on hematoxylin and eosin–stained sections
(see Figure 4a). In DT skin, there was increased dermal
CD45þ infiltrates (Figure 1e), coupled with increased expres-
sion of proinflammatory cytokines and chemokines such as
TNF-a (tumor necrosis factor-a), IL-6, IL-23, IL-1b, IL-1a,
CXCL1/2, S100A8/9, G-CSF (granulocyte colony-stimulating
factor), and GM-CSF (Supplementary Figure S1b online), as
well as DefB2, Camp, and S100A7; genes associated with
human psoriasis (Supplementary Figure S1c online). DT skin
had multiple intraepidermal microabscesses filled with
myeloperoxidaseþ neutrophils (Figure 1c and f), and the
majority of resident leukocytes were Ly6Gþ /CD11bþ neu-
trophils (Figure 1k), but there was also an increase in mast
cells (Figure 1g and h) and F4/80þ cells (Figure 1i and j).
When DT mice were placed back on dox, reversal of the
inflamed skin phenotype, hair regrowth, and resolution of
systemic neutrophilia were observed within 3 weeks
(Supplementary Figure S2 online). Neutrophils isolated from
the spleens of DT mice had increased reactive oxygen species
relative to control mice (Figure 1l) and were cytotoxic in vitro
to the papilloma tumor cell line, SP-1 (Figure 1m), and
primary mouse keratinocytes (not shown). Antibody depletion
of Gr-1þ cells before and during RAS expression prevented
microabscess formation (Supplementary Figure S3a online),
indicating that neutrophils were the main driver of epidermal
cytotoxicity, but there was little effect on epidermal prolifera-
tion (Supplementary Figure S3b and c online).
Suprabasal RAS expression increases Th17, cd-17, and Tc1/Tc17
skin residency
Suprabasal RAS expression also caused a significant increase
in absolute numbers of skin-infiltrating CD4þ and CD8þ
T cells determined by semiquantitative FACS, with all of
the CD8þ T cells in the epidermis and the majority but not all
of CD4þ T cells residing in the dermis (Figure 2a). Approxi-
mately 68% of skin-infiltrating CD3þ T cells were CD4þ and
5% were CD8þ T cells, as measured by FACS (not shown).
In addition, there was an increase in activated and IFN-g-
expressing CD4þ and CD8þ T cells and Tregs (regulatory
T cells) in skin-draining lymph node (SDLN) (Supplementary
Figure S4a–c online). IL-17Aþ T cells were undetectable in
SDLN (data not shown), and Th2 cells were undetectable in
SDLN and skin of RAS-expressing mice (Supplementary Figure
S4d online). In the normal skin, 14% of CD4þ T cells and
25% of gd T cells expressed IFN-g and 0.9 and 2.7% were IL-
17Aþ , respectively (Figure 2b and c). Following induction of
RAS, the frequency of Th1 and IFN-gþ gd T cells did not
change, but there was anB5-fold increase in the frequency of
Th17 cells, and a 2-fold increase in the percentage of IL-17A-
expressing gd T cells (Figure 2b and c). There was also a
substantial increase in FoxP3þ cells in DT skin (Figure 2d). By
contrast, 86% of skin CD8þ T cells in DT mice were IFN-gþ
(Figure 2e). Nearly 75% of the skin-infiltrating CD8þ T cells
coexpressed both IL-17A and IFN-g, and B50% of these
double-positive CD8 cells also expressed the cytolytic
effectors granzyme B and perforin (Figure 2f). A small per-
centage (B1%) of CD8þ T cells were detected in ST skin, but
IFN-g and IL-17A cytokine expression was undetectable (data
not shown).
CD8þ T lymphocytes drive epidermal microabscess formation,
Th17 infiltration, and maximal keratinocyte proliferation
To test the importance of lymphocytes in the inflammatory
response, the inducible transgenes were placed on a
Rag1 / background (DTRag1 / ). In the absence of
lymphocytes, RAS-induced myeloperoxidaseþ epidermal
microabscesses (Figure 3a–d) and neutrophil and mast cell
skin infiltration were suppressed (Figure 3d, e, and g) but
macrophage infiltration was unaffected (Figure 3f). Inducible
nitric oxide synthase, elevated in keratinocytes, neutrophils,
and CD11cþ cells of psoriatic patients (Bruch-Gerharz et al.,
1996; Lowes et al., 2005), was also increased in DT skin and
suppressed in DTRag1 / skin (Figure 3h). Suprabasal RAS-
induced proliferation decreased from 42 to 30% BrdUþ basal
keratinocytes/field of view (Figure 3i), with a corresponding
reduction in epidermal thickness in DTRag1 / skin
(Figure 3j).
Initial studies showed that adoptive transfer of CD3þ T cells
into DTRag1 / mice restored neutrophil microabscesses
(data not shown). To determine the importance of CD4þ or
CD8þ T cells in this pathology, we depleted these lympho-
cyte subsets from DT mice with antibodies. Depletion effi-
ciency was X99% as measured by FACS from blood, spleen,
and LNs (not shown). Depletion of CD4þ T cells had no effect
on RAS-induced epidermal microabscesses (Figure 4b) or the
severity of neutrophilia (Supplementary Figure S5 online), and
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slightly enhanced the percentage of CD11bþ /Ly6Gþ skin
infiltrates (Figure 4d). However, depletion of CD8þ T cells
suppressed microabscesses (Figure 4c), reduced circulating
neutrophil numbers (Supplementary Figure S5 online), and
caused a 2-fold reduction in cutaneous CD11bþ /Ly6Gþ cells
(Figure 4d). CD8þ , but not CD4þ , T-cell depletion sup-
pressed RAS-activated keratinocyte proliferation from 42
to 28% BrdUþ basal cells, similar to that found in the
DTRag1  / mice (Figure 4e).
CD8þ T cells are sufficient to cause epidermal microabscess
formation and enhance keratinocyte proliferation
To determine whether CD8þT cells could restore RAS-
induced cutaneous inflammation and enhance keratinocyte
proliferation, we reconstituted DTRag1 / mice with pur-
ified LN and splenic CD8þ T cells, and induced RAS
expression for 7 days. Similar to CD3-repleted mice (not
shown), transferred CD8þ T cells restored microabscesses
(Figure 4g), neutrophil skin infiltration (Figure 4h), and
keratinocyte proliferation (Figure 4i) in the absence of other
lymphocytes. Reconstituting naive ST littermates with CD8þ
T cells had no effect on inflammation and epidermal prolife-
ration. FACS analysis of LNs demonstrated successful recon-
stitution in all CD8-repleted mice (data not shown).
CD8þ T cells aid in CD4þ T-cell activation and skin residency
of Th17 and cd-17 cells
As CD8þ , but not CD4þ , T lymphocytes were critical for the
neutrophil-driven pathology, we examined their importance in
mediating other RAS-induced inflammatory effects. In DT
mice, depletion of CD8þ T cells significantly reduced the
increase of effector CD4þ T cells (CD44hi/CD62lo) in inguinal
LN (Figure 5a) and dampened CD4þ T-cell infiltration into the
skin (Figure 5b). CD8 depletion also blocked the increase in
skin Th17 and IL-17þ gd T cells (Figure 5c). By contrast, CD4
depletion increased CD8þ T-cell effector differentiation in LN
(Figure 5d). These results suggest that CD8þ T cells are
instrumental in orchestrating global inflammatory changes
associated with suprabasal activation of RAS.
IFN-c, and not IL-17, mediates CD8þ T-cell-driven inflammation
As IFN-g- and IL-17A-expressing CD8þ T cells were present
in inflamed skin of DT mice, we tested whether either
cytokine was responsible for the CD8-driven inflammatory
responses. CD8þ T-cell-transferred DTRag1 / mice were
injected with neutralizing antibodies to IL-17A or IFN-g, and
parameters of skin inflammation were measured after RAS
induction. Surprisingly, neutralization of IL-17A had no effect
on neutrophil infiltration (Figure 6a). By contrast, anti-IFN-g
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Figure 1. Suprabasal expression of H-RASV12G in adult epidermis causes psoriasis-like phenotype with intraepidermal microabscesses. (a) Photographs of
representative shaved double-transgenic (DT) mice on doxycycline (dox; right) or off dox (left) for 7 days. Representative skin sections from (b, g, i) single-
transgenic (ST) mice or (c–f, h, j) DT mice off dox for 7 days. (b) Hematoxylin and eosin (H&E)–stained ST skin. (c) H&E–stained DT section (arrow indicates
intraepidermal microabscesses). IHC detection of (d) proliferation (anti-BrdU), (e) leukocytes (anti-CD45), (f) neutrophils (anti-myeloperoxidase), (g, h) mast cells
(toluidine blue (Tol. blue)), and (i, j) macrophages (anti-F4/80; original magnification 20). Arrows indicate representative stained cells. (k) FACS profile (n¼ 5
mice) of Ly6Gþ /CD11bþ cells from ST or DT skin gated on viable CD45þ cells. (l) Flow histogram of H2DCFDA fluorescence in neutrophils from ST and DT
mice. (m) In vitro cytotoxicity assay of sorted splenic Ly6Gþ /CD11bþ cells using SP1 papilloma cells as target. Data are from three independent experiments
performed in triplicate; error bars¼±SEM. *Significantly different from ST Ly6Gþ cells. Bars¼20mm (b–f) and 100mm (g–j). MPO, myeloperoxidase; ROS,
reactive oxygen species.
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reduced Ly6Gþ skin infiltration (Figure 6b; Supplementary
Figure S6 online), epidermal hyperplasia (Figure 6c), and
keratinocyte proliferation (Figure 6d). Finally, inducible nitric
oxide synthase, a direct target of IFN-g, was reduced in CD8-
repleted, IFN-g-neutralized skin relative to isotype control
groups (Figure 6e), suggesting that CD8þ T cells alone could
cause inducible nitric oxide synthase upregulation through the
paracrine activities of IFN-g from CD8þ T cells or other
cellular sources responding to transferred CD8þ T cells.
DISCUSSION
Here we have documented a mouse model of suprabasal RAS
expression that recapitulates many features of a psoriasis-like
skin phenotype, including basal keratinocyte hyperprolifera-
tion, acanthosis, hyperkeratosis, T-cell-driven inflammation
dominated by neutrophil infiltration, and formation of intrae-
pidermal neutrophil microabscesses. Similar pathologies
(Munro’s microabscesses) have been observed in severe
pustular psoriasis, as well as in psoriatic-like mouse models,
including protein kinase C a overexpression targeted to basal
layer epithelia (Cataisson et al., 2003, 2006) and topical
imiquimod application (van der Fits et al., 2009). Our results
suggest that this cytotoxic damage is caused by hyperactivated
neutrophils dependent on CD8þ T cells.
With minor differences such as the extent of microabscess
formation, the skin phenotype is similar to other mouse
models that express individual components of the RAS–RAF–
MAPK pathway or EGFR ligands that likely activate this
pathway (Cook et al., 2004; Hobbs et al., 2004; Tarutani
et al., 2010). Suprabasal RAS causes a CD4þ predominant
T-cell skin infiltrate, with a significant increase in
intraepidermal CD8þ T cells similar to suprabasal MAPK/
ERK kinase expression (Hobbs et al., 2004) and psoriatic skin.
Consistent with the biology of psoriasis (Di Cesare et al., 2009;
Cai et al., 2011; Monteleone et al., 2011), we observed a
significant increase in the percentage of Th17 and IL-17þ gd
T cells in RAS-expressing skin. As we did not detect IL-17þ
T cells in SDLN, it is likely that this represents polarization of
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Figure 2. RAS triggers skin infiltration of CD4þ and CD8þ T cells expressing IFN-c and IL-17A. (a) Top: CD4þ and TCRbþ /CD8þ T-cell counts in the skin
of single-transgenic (ST) and double-transgenic (DT) mice. N¼ 5 ST and 6 DT mice from two experiments. Bottom: Immunohistochemical (IHC) localization of
CD4þ T-cell infiltration (left) in the dermis and CD8þ T-cell infiltration (right) in the epidermis of DT mice. (b, c, e) Intracellular FACS analysis for IL-17A
and IFN-g obtained from the stimulated skin single-cell suspensions gated on viable/CD45þ cells and CD4þ (b), gd TCRþ (c), and CD8þ (e) cells. (d) FoxP3 IHC
in ST and DT skin. (f) Perforin/granzyme B FACS on IFN-gþ /IL-17þ /CD8þ T cells. CD8þ T cells from ST mice were too scarce for analysis. Means±SEM from at
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these cells within the skin microenvironment due to elevated
IL-6, IL-23 (Supplementary Figure S1b online), and TGFb1
(transforming growth factor b1; Glick et al., 1991). Despite
their abundance in lesional skin, depletion of CD4þ T cells
had no effect on keratinocyte proliferation, neutrophil skin
infiltration, or microabscess formation, but instead slightly
increased percentage of skin Ly6Gþ cells and activated
CD8þ T cells in the SDLN. This suggests that a significant
fraction of CD4þ T cells are primarily functioning as Tregs,
and this is supported by increased Treg numbers in the skin
and SDLN following RAS expression (Figure 2d and
Supplementary Figure S1d online). Similar results were
obtained in a K14-VEGF (K14-vascular endothelial growth
factor) model of psoriasis-like inflammation, where CD4
depletion enhanced ear thickness and increased proinflamma-
tory cytokine expression (Teige et al., 2009). In addition, CD4
depletion in another psoriasis-like model (Involucrin-a2b1
integrin transgenic) had little effect on disease pheno-
type, but the role of CD8þ T cells was not examined
(Teige et al., 2010).
Although CD8þ T cells infiltrating the skin in response to
RAS represent a minor component of total T cells, our data
suggest that they are critical for initiating the psoriasis-like
phenotype. Although epidermal microabscesses were caused
by neutrophils, the neutrophil inflammatory phenotype and
maximal keratinocyte hyperproliferation were dependent on
CD8þ T cells. Thus, the psoriasiform pathology was amelio-
rated on a Rag1 / background and by depletion of CD8þ
T cells, whereas naive CD8þ T-cell reconstitution into
DTRag1 / mice restored these phenotypes. Conversely,
infiltration of F4/80þ cells was independent of lymphocytes
and may be contributing to the observed residual epidermal
hyperplasia in DTRag1 / mice. Strikingly, depletion of
CD8þ T cells reduced the percentage of activated CD4þ
T cells in SDLN and Th17 and IL-17þ gd T cells in the skin.
It is possible that CD8þ T cells are required for initiating or
propagating an inflammatory signal that indirectly activates
SDLN CD4þ T cells and an inflammatory microenvironment
that causes Th17 polarization of skin-infiltrating CD4 T cells,
but more studies are needed to determine the underlying
mechanism.
The overwhelming majority (B75%) of skin-infiltrating
CD8þ T cells coexpressed both IFN-gþ and IL-17þ , and
the majority of these also expressed the cytotoxic effectors
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granzyme B and perforin. These results are similar to those of
Ortega and colleagues who found cytotoxic activity in
ex vivo––isolated IFN-gþ /IL-17þ CD8þ T cells from psoriatic
plaques (Ortega et al., 2009) and suggest greater plasticity in
CD8 polarization. By contrast, in vitro–conditioned Tc17
differentiation is associated with reduced cytotoxicity and
downregulation of perforin, granzyme B, and the
transcription factor Eomes (Hinrichs et al., 2009; Yen et al.,
2009). Thus, further study of the cytotoxic and molecular
profile of these RAS-activated CD8þ T cells is needed to
understand their unique properties and relationship with
psoriatic CD8þ T cells.
Both IFN-g and IL-17 have significant roles in psoriasis (Di
Cesare et al., 2009; Monteleone et al., 2011), but the
importance CD8þ T cell as a source for these cytokines is
not clear. Within the context of this suprabasal RAS model,
IFN-g has a primary role during disease onset, as
neutralization of IFN-g, but not of IL-17A, in CD8-
reconstituted, RAS-expressing Rag1 / mice suppressed
neutrophil skin infiltration and keratinocyte proliferation.
Although it remains to be directly demonstrated that IFN-g
from CD8þ T cells is responsible, the observations that
CD8þ T cells infiltrate the epidermis in response to RAS
coupled with multiple studies showing that IFN-g can
induce epidermal hyperproliferation (Barker et al., 1993;
Sarra et al., 2011) suggest that this may be a direct effect.
As IFN-g can program antigen-presenting cells to induce
IL-17þ T cells (Kryczek et al., 2008), it is plausible that
CD8-derived IFN-g can provide the same signal. Given the
strong evidence linking the IL-17/23 axis to the
pathogenesis of psoriasis (Di Cesare et al., 2009), it is
not clear whether these results represent a peculiarity to
this model or reflect an initial requirement for CD8þ T
cells for the response that is sustained and amplified by IL-
17-expressing CD4 or gd T cells. It is also possible that IL-
17F rather than IL17A is critical for the inflammatory
changes we observe here (Iwakura et al., 2011). Adoptive
transfer studies using Ifng  / and Il-17 / CD4þ and
CD8þ T cells are needed to elucidate the relative
contributions of each of these cytokines.
It is surprising that the more abundant IFN-gþ CD4þ and
gd T cells in the RAS-expressing skin do not fulfill the same
function as IFN-gþ /CD8þ T cells. Likely, an additional CD8-
specific cytokine such as TNF-a is required along with IFN-g
to drive the cytotoxic neutrophil phenotype, as IFN-g/IL-17-
coexpressing CD8þ T cells also upregulate TNF-a in psoriasis
and murine skin tumors (Roberts et al., 2007; Ortega et al.,
2009). Although we have observed increased TNF-a and IL-1a
in RAS-expressing skin, the importance of these clinically
relevant cytokine pathways remains to be determined.
However, epidermal localization of CD8þ T cells may also
be critical for initiating inflammation that is further amplified
and maintained by Th1 and Th17 cells in the dermis. In
support of this, epidermal localization of VLA-1 (very late
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antigen-1; a1b1)þ IFN-gþ CD3þ cells correlated with
disease progression of psoriatic lesions, and inhibition of
epidermal T-cell infiltration reduced the psoriasiform pheno-
type (Conrad et al., 2007). Moreover, a CXCL16/CXCR6
signaling axis appears to be critical for epidermal infiltration
of CD8þ , but not of CD4þ , T cells in psoriasis (Gunther et al.,
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2012). Whether the intraepidermal localization of CD8þ T
cells is necessary in the suprabasal RAS model and whether it
is driven by a similar CXCL16/CXCR6 chemotactic pathway
remain to be tested.
Taken together, our model of suprabasal RAS expression
parallels the CD8þ T-cell phenotype from psoriatic
patients, and highlights the ability of these cells to initiate
skin inflammation and keratinocyte proliferation, and
regulate the abundance of skin Th17 cells. This model could
represent a unique tool to understand the role of CD8þ T cells
in the pathogenesis of skin inflammatory diseases, such as
psoriasis.
MATERIALS AND METHODS
Animal studies
InvtTA mice (Jaubert et al., 2004) were crossed with a homozygous
tetOHRASV12G line (Chin et al., 1999) to yield tetORAS (ST) and DT
InvtTA/tetOHRASV12G offspring, and genotypes were determined by
PCR. Transgene induction was suppressed by dox (10mg ml 1) in
drinking water of breeding pairs and ST- and DT-weaned mice, and
6–8-week-old mice were placed on water without dox to induce RAS
expression. No difference in histology or immune parameters was
seen between ST dox and DTþ dox mice. Leukocytes were
depleted with 500mg of RB6-8C5 (a-Gr-1), GK1.5 (a-CD4),
YTS169.4 (a-CD8b), and HB94 (IgG) monoclonal antibodies were
administered intraperitoneally every other day (a-Gr-1) or once (a-
CD4, a-CD8b) coincident with dox removal, and 495% depletion
was validated by flow cytometry. InvtTA and tetORAS transgenes
were bred onto a Rag1 / background to assess lymphocyte
function. Rag1 / mice were reconstituted by retro-orbital transfer
of 5 million negatively selected FACS- and/or MACS (Miltenyi Biotec,
Auburn, CA)-purified T cells isolated from the inguinal LNs and
spleen of nontransgenic FVB/n mice (1:4 ratio) 2 days before
transgene induction. Purities of 495% were routinely achieved for
adoptive transfer, and repletion was validated by flow cytometry.
Differential leukocyte counts were determined on a Mascot Hemavet
950FS blood analyzer (Drew Scientific, Waterbury, CT). A measure of
500mg of neutralizing a-IFN-g, XMG1.2 (BioXcell, West Lebanon,
NH), a-IL-17A, and TC11-18H10.1 (Biolegend, San Diego, CA)
antibodies were administered intraperitoneally every 3 days
beginning on day 0 through one day before killing the animal.
To measure proliferation, mice were injected intraperitoneally
with 6 mg of BrdU (Sigma-Aldrich, St Louis, MO) 1 hour before
killing. All mice were on a FVB/n background and animal studies
were conducted in compliance with the US Department of Health
and Human Services Guide for the Care and Use of Laboratory
Animals following protocols approved by The Pennsylvania State
University IACUC.
Cytotoxicity assay
Detection of neutrophil-mediated cytotoxicity was done as described
(Corey et al., 1997), with modifications, using the KDalert GAPDH
(glyceraldehyde-3-phosphate dehydrogenase) Assay Kit (Applied Bio-
systems, Foster City, CA) to quantitate GAPDH. Percentage of cyto-
toxicity was calculated using the following equation: % killing¼
(GAPDHCo-culture (GAPDHeffectorsþGAPDHtarget))/GAPDHtotal effector
lysates 100.
FACS analysis
FACS analysis of single-cell suspensions isolated from dorsal skin was
performed as described (Mohammed et al., 2010). Intracellular
cytokines were detected by treating single-cell suspensions with
PMA/ionomycin and Brefeldin A (eBioscience, San Diego, CA) for
4½ hours at 37 1C. Cells were stained for extracellular surface
antigens, fixed with 4% paraformaldehyde, and permeabilized with
0.2% saponin/1% BSA/1 PBS. Reactive oxygen species was mea-
sured in CD11bþ /Ly6Gþ cells using the dye carboxy-H2DCFDA
(Molecular Probes, Eugene, OR) according to the manufacturer’s
protocol. Fluorescently stained single-cell suspensions were analyzed
on an FC500 (Beckman Coulter, Indianapolis, IN) or an LSRFortessa
(BD Biosciences, San Jose, CA) cytometer. Cell sorting was performed
on a Cytopeia Influx Sorter (BD Biosciences).
Statistical analysis
Student’s t-test was used to calculate P-values between experimental
groups of two only. For groups of X3, one-way analysis of variance
was used along with Tukey’s post-analysis t-tests. GraphPad
Prism, version 4.0 (La Jolla, CA) was used to format all figures and
calculate significance. *Po0.05.
Flow antibodies, tissue analysis, and biochemical and molecular
analysis are described in Supplementary Materials online.
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